Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy

INTRODUCTION<br/> Only a minority of esophageal cancers demonstrates a pathological tumor response (pTR) to neoadjuvant chemotherapy (NAC). 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) is often used for restaging after NAC and to assess response. Incre...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Findlay, J, Bradley, K, Mun Wang, L, Franklin, J, Teoh, E, Gleeson, F, Maynard, N, Gilies, R, Middleton, M
Μορφή:	Journal article
Έκδοση:	Society of Nuclear Medicine 2016

Παρόμοια τεκμήρια

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
ανά: Findlay, J, κ.ά.
Έκδοση: (2017)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
ανά: Findlay, J, κ.ά.
Έκδοση: (2017)

Neutrophil-lymphocyte ratio and nodal pathologic complete response in node positive breast cancer patients undergoing neoadjuvant chemotherapy
ανά: M.L. Gasparri, κ.ά.
Έκδοση: (2021-04-01)

Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis
ανά: Charles E. Gaber, κ.ά.
Έκδοση: (2024-02-01)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
ανά: Kunnuru SKR, κ.ά.
Έκδοση: (2020-11-01)

Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
ανά: Li-Jun Wei, κ.ά.
Έκδοση: (2024-07-01)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
ανά: Gillies, R, κ.ά.
Έκδοση: (2011)

Extended Sentinel Node Biopsy in Breast Cancer Patients who Achieve Complete Nodal Response with Neoadjuvant Chemotherapy
ανά: Alfredo Carlos Simões Dornellas de Barros, κ.ά.
Έκδοση: (2020-04-01)

DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
ανά: Jinrong Qu, κ.ά.
Έκδοση: (2022-01-01)

The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
ανά: Yanan Lu, κ.ά.
Έκδοση: (2019-10-01)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
ανά: G.W. van Pelt, κ.ά.
Έκδοση: (2020-01-01)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
ανά: Ali Kermani, κ.ά.
Έκδοση: (2020-01-01)

A study of the assessment of pathological response to neoadjuvant chemotherapy in patients with breast cancer
ανά: Supriya Mallige, κ.ά.
Έκδοση: (2024-08-01)

Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
ανά: François Bertucci, κ.ά.
Έκδοση: (2024-10-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
ανά: Yoshitaka Shimamaki, κ.ά.
Έκδοση: (2024-02-01)

Efficacy of Mammographic Artificial Intelligence-Based Computer-Aided Detection in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy
ανά: Ga Eun Park, κ.ά.
Έκδοση: (2024-11-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
ανά: Guihong Liu, κ.ά.
Έκδοση: (2024-03-01)

Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
ανά: Dante J. Merlino, κ.ά.
Έκδοση: (2020-12-01)

Assessment of clinical and pathological response to neoadjuvant chemotherapy in breast cancer according to molecular subtypes
ανά: Rabab Mohammed Ali HASAN, κ.ά.
Έκδοση: (2024-09-01)

Influencing factors of pathological complete response in triple-negative breast cancer with neoadjuvant chemotherapy
ανά: DUAN Shuai, κ.ά.
Έκδοση: (2024-03-01)

Pathological response of different molecular subtypes of locally advanced breast carcinoma to neoadjuvant chemotherapy
ανά: Nidhi Aley Alex, κ.ά.
Έκδοση: (2023-08-01)

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
ανά: Uanderson Resende, κ.ά.
Έκδοση: (2019-06-01)

Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
ανά: Sunghoon Joo, κ.ά.
Έκδοση: (2021-09-01)

Assessment of pathological response to neoadjuvant chemotherapy in patients with breast carcinoma using Sataloff system
ανά: Savita Agarwal, κ.ά.
Έκδοση: (2019-01-01)

MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
ανά: Franklin, J, κ.ά.
Έκδοση: (2012)

18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
ανά: Nicola Simoni, κ.ά.
Έκδοση: (2020-11-01)

Neoadjuvant Chemotherapy in Esophageal Cancer: Single Institution Experience
ανά: Shaffi Shaikh, κ.ά.
Έκδοση: (2011-10-01)

Response of Neoadjuvant Chemotherapy in Triple Negative Breast Cancer and the Impact of Pathologic Complete Response on Survival, an Institutional Research
ανά: Muhammad Rashid Hanif, κ.ά.
Έκδοση: (2024-06-01)

Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis
ανά: Maria Luisa Gasparri, κ.ά.
Έκδοση: (2023-08-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
ανά: Lei Xu, κ.ά.
Έκδοση: (2022-11-01)

Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
ανά: Yuli Ruan, κ.ά.
Έκδοση: (2024-05-01)

Major pathological response after neoadjuvant immunotherapy in esophageal spindle cell carcinoma: A case report
ανά: Yang Fu, κ.ά.
Έκδοση: (2021-04-01)

Would clipping and removal of all ultrasound abnormal metastatic lymph nodes predict nodal response in breast cancer patients with neoadjuvant chemotherapy?
ανά: G.H. Lim, κ.ά.
Έκδοση: (2021-04-01)

The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery
ανά: Mina M. G. Youssef, κ.ά.
Έκδοση: (2021-02-01)

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
ανά: Elizabeth A Guancial, κ.ά.
Έκδοση: (2016-01-01)

Assessment of Pathological Response of Breast Carcinoma in Modified Radical Mastectomy Specimens after Neoadjuvant Chemotherapy
ανά: Dhanya Vasudevan, κ.ά.
Έκδοση: (2015-01-01)